Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia

被引:126
作者
Kim, Dong Hwan [1 ,2 ]
Kamel-Reid, Suzanne [3 ]
Chang, Hong [4 ]
Sutherland, Robert [4 ]
Jung, Chul Won
Kim, Hyeoung-Joon [5 ]
Lee, Je-Jung [5 ]
Lipton, Jeffrey H. [2 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med Hematol Oncol,Div Hemato Oncol, Seoul, South Korea
[2] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network,Dept Hematol Med Oncol, Chron Myelogenous Leukemia Grp, Toronto, ON, Canada
[3] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Haematol Lab, Toronto, ON, Canada
[5] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, Jeollanamdo, South Korea
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 01期
关键词
lymphocytosis; large granular lymphocyte; natural killer cells; dasatinib; CHRONIC MYELOGENOUS LEUKEMIA; KINASE FYN; IMATINIB MESYLATE; TERM CULTURE; NK CELLS; ACTIVATION; PROLIFERATION; CYTOTOXICITY; MODULATION; EXPRESSION;
D O I
10.3324/haematol.13151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dasatinib, a dual tyrosine kinase inhibitor, is known to modulate or suppress T-cell activation and proliferation. We report a series of 8 patients who developed chronic peripheral lymphocytosis, identified as natural killer cells or natural killer/T-cells based on their large granular lymphocyte morphologies and CD16(+), CD56(+), CD3(-) or CD3(+) immunophenotypic profiles, out of 18 patients receiving dasatinib therapy. All cases that developed large granular lymphocyte lymphocytosis achieved optimal molecular response (8/8 in large granular lymphocyte(+) patients vs. 3/10 in large granular lymphocyte(-) patients, p=0.002). A Cr-51 release assay demonstrated that natural killer cell cytotoxicity has been enhanced in a case of large granular lymphocyte lymphocytosis compared to normal healthy donors, and that natural killer cell cytotoxicity in dasatinib-responders was superior to that in non-responders. In summary the present study suggests that natural killer or natural killer/T cell lineage large granular lymphocyte lymphocytosis develops in association with dasatinib therapy and that large granular lymphocyte might have a therapeutic effect on Ph+ leukemic cells.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 22 条
[1]   Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn [J].
Bloch-Queyrat, C ;
Fondanèche, MC ;
Chen, RY ;
Yin, L ;
Relouzat, F ;
Veillette, A ;
Fischer, A ;
Latour, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (01) :181-192
[2]   BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia [J].
Boissel, Nicolas ;
Rea, Delphine ;
Tieng, Vannary ;
Dulphy, Nicolas ;
Brun, Manuel ;
Cayuela, Jean-Michel ;
Rousselot, Philippe ;
Tamouza, Ryad ;
Le Bouteiller, Philippe ;
Mahon, Francois-Xavier ;
Steinle, Alexander ;
Charron, Dominique ;
Dombret, Herve ;
Toubert, Antoine .
JOURNAL OF IMMUNOLOGY, 2006, 176 (08) :5108-5116
[3]   Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects [J].
Borg, C ;
Terme, M ;
Taïeb, J ;
Ménard, C ;
Flament, C ;
Robert, C ;
Maruyama, K ;
Wakasugi, H ;
Angevin, E ;
Thielemans, K ;
Le Cesne, A ;
Chung-Scott, V ;
Lazar, V ;
Tchou, I ;
Crépineau, F ;
Lemoine, F ;
Bernard, J ;
Fletcher, JA ;
Turhan, A ;
Blay, JY ;
Spatz, A ;
Emile, JF ;
Heinrich, MC ;
Mécheri, S ;
Tursz, T ;
Zitvogel, L .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03) :379-388
[4]   The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formation [J].
Cebo, C ;
Da Rocha, S ;
Wittnebel, S ;
Turhan, AG ;
Abdelali, J ;
Caillat-Zucman, S ;
Bourhis, JH ;
Chouaib, S ;
Caignard, A .
JOURNAL OF IMMUNOLOGY, 2006, 176 (02) :864-872
[5]   Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture [J].
Cervantes, F ;
Pierson, BA ;
McGlave, PB ;
Verfaillie, CM ;
Miller, JS .
BLOOD, 1996, 87 (06) :2476-2485
[6]  
CHANG WC, 1991, NAT IMMUN CELL GROW, V10, P57
[7]   The Src family tyrosine kinase Fyn regulates natural killer T cell development [J].
Gadue, P ;
Morton, N ;
Stein, PL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08) :1189-1195
[8]   T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders [J].
Hong, C ;
Kamel-Reid, S ;
Hussain, N ;
Lipton, J ;
Messner, HA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (02) :196-199
[9]   Modulation of T-effector function by imatinib at the level of cytokine secretion [J].
Leder, Christoph ;
Ortler, Sonja ;
Seggewiss, Ruth ;
Einsele, Hermann ;
Wiendl, Heinz .
EXPERIMENTAL HEMATOLOGY, 2007, 35 (08) :1266-1271
[10]  
Lowin-Kropf B, 2002, EUR J IMMUNOL, V32, P773, DOI 10.1002/1521-4141(200203)32:3<773::AID-IMMU773>3.0.CO